Krishnamohan Neha
Insider CIK 1866171 · ARQT Director · KNTE Chief Financial Officer · ARTV Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2026-06-05 | 2026-06-09 | 16,667 | — | $0 | 16,667 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2026-06-05 | 2026-06-09 | 5,778 | — | $0 | 27,901 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | F Tax w/h | 2025-11-15 | 2025-11-17 | 3,490 | $3.25 | $11.3K | 99,356 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise deriv | 2025-11-13 | 2025-11-17 | 12,220 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise deriv | 2025-11-13 | 2025-11-17 | 27,052 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise | 2025-11-13 | 2025-11-17 | 27,052 | $8.63 | $233.5K | 50,407 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | M Exercise | 2025-11-13 | 2025-11-17 | 12,220 | $7.51 | $91.8K | 62,627 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-11-13 | 2025-11-17 | 39,272 | $23.19 | $910.7K | 23,355 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-11-13 | 2025-11-17 | 1,232 | $23.37 | $28.8K | 22,123 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | F Tax w/h | 2025-08-15 | 2025-08-18 | 5,813 | $2.75 | $16.0K | 102,846 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2025-06-12 | 2025-06-16 | 20,568 | — | $0 | 20,568 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2025-06-12 | 2025-06-16 | 7,609 | — | $0 | 23,355 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | F Tax w/h | 2025-05-15 | 2025-08-18 | 1,341 | $2.13 | $2.9K | 108,659 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award | 2025-02-26 | 2025-02-28 | 60,000 | — | $0 | 110,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award | 2024-09-12 | 2024-09-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2024-06-14 | 2024-06-18 | 27,052 | — | $0 | 27,052 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-06-14 | 2024-06-18 | 10,139 | — | $0 | 15,746 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 185,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 215,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 270,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 64,087 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 1,506 | $2.59 | $3.9K | 64,087 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2023-12-01 | 2023-12-05 | 1,459 | $2.25 | $3.3K | 65,593 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2023-09-01 | 2023-09-06 | 1,459 | $2.35 | $3.4K | 67,052 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2023-06-01 | 2023-06-05 | 1,459 | $4.30 | $6.3K | 68,511 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2023-05-31 | 2023-06-02 | 12,220 | — | $0 | 12,220 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-05-31 | 2023-06-02 | 4,375 | — | $0 | 5,607 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2023-03-01 | 2023-03-03 | 1,721 | $5.21 | $9.0K | 67,378 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2023-02-10 | 2023-02-14 | 215,000 | — | $0 | 215,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | F Tax w/h | 2022-12-01 | 2022-12-02 | 1,459 | $7.75 | $11.3K | 69,099 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2022-09-02 | 2022-09-06 | 29,482 | — | $0 | 29,482 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2022-09-01 | 2022-09-02 | 67,500 | — | $0 | 69,015 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 185,000 | — | $0 | 185,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2021-06-07 | 2021-06-08 | 270,000 | — | $0 | 270,000 | SEC↗ |